NEAT 1 knockdown enhances the sensitivity of human non-small-cell lung cancer cells to anlotinib

Anlotinib treatment of non-small cell lung cancer (NSCLC) is hindered by drug insensitivity. Downregulation of long non-coding RNA (lncRNA) NEAT1 can suppress the proliferation and invasion by NSCLC cells. This study explored the role of the combination of anlotinib with NEAT1 knockdown on NSCLC pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Guoqing, Hu, Chenxi, Hui, Kaiyuan, Chen, Ting, Zhang, Huiqin, Jiang, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202848/
https://www.ncbi.nlm.nih.gov/pubmed/33982669
http://dx.doi.org/10.18632/aging.203004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202848/
https://www.ncbi.nlm.nih.gov/pubmed/33982669
http://dx.doi.org/10.18632/aging.203004

Ejemplares similares